nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—CHRM1—epilepsy syndrome	0.391	1	CbGaD
Doxylamine—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.0473	0.123	CrCrCtD
Doxylamine—Doxepin—Oxcarbazepine—epilepsy syndrome	0.0464	0.121	CrCrCtD
Doxylamine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.039	0.102	CrCrCtD
Doxylamine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0368	0.096	CrCrCtD
Doxylamine—Imipramine—Carbamazepine—epilepsy syndrome	0.0353	0.092	CrCrCtD
Doxylamine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.0339	0.0884	CrCrCtD
Doxylamine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.0325	0.0848	CrCrCtD
Doxylamine—Benzphetamine—Phenytoin—epilepsy syndrome	0.0313	0.0817	CrCrCtD
Doxylamine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0278	0.0726	CrCrCtD
Doxylamine—Promazine—Carbamazepine—epilepsy syndrome	0.0276	0.072	CrCrCtD
Doxylamine—Promazine—Oxcarbazepine—epilepsy syndrome	0.0254	0.0663	CrCrCtD
Doxylamine—Disopyramide—KCND2—epilepsy syndrome	0.000413	0.0827	CrCbGaD
Doxylamine—Methadyl Acetate—OPRM1—epilepsy syndrome	0.000192	0.0383	CrCbGaD
Doxylamine—Imipramine—KCND2—epilepsy syndrome	0.000155	0.0309	CrCbGaD
Doxylamine—Amitriptyline—KCND2—epilepsy syndrome	0.000154	0.0307	CrCbGaD
Doxylamine—Isopropamide—CHRM3—epilepsy syndrome	0.00015	0.03	CrCbGaD
Doxylamine—Amitriptyline—KCNQ2—epilepsy syndrome	0.000143	0.0286	CrCbGaD
Doxylamine—Amitriptyline—KCNQ3—epilepsy syndrome	0.000143	0.0286	CrCbGaD
Doxylamine—Isopropamide—CHRM1—epilepsy syndrome	0.00014	0.028	CrCbGaD
Doxylamine—Amitriptyline—NTRK2—epilepsy syndrome	0.000121	0.0243	CrCbGaD
Doxylamine—Orphenadrine—SCN9A—epilepsy syndrome	0.000119	0.0237	CrCbGaD
Doxylamine—Disopyramide—CHRM3—epilepsy syndrome	0.000114	0.0227	CrCbGaD
Doxylamine—Orphenadrine—SCN4A—epilepsy syndrome	0.000109	0.0218	CrCbGaD
Doxylamine—Disopyramide—CHRM1—epilepsy syndrome	0.000106	0.0212	CrCbGaD
Doxylamine—Dimetindene—CHRM2—epilepsy syndrome	9.99e-05	0.02	CrCbGaD
Doxylamine—Dextropropoxyphene—OPRD1—epilepsy syndrome	9.42e-05	0.0188	CrCbGaD
Doxylamine—Disopyramide—CHRM2—epilepsy syndrome	8.66e-05	0.0173	CrCbGaD
Doxylamine—Brompheniramine—CHRM3—epilepsy syndrome	8.45e-05	0.0169	CrCbGaD
Doxylamine—Levomethadyl Acetate—OPRM1—epilepsy syndrome	8.34e-05	0.0167	CrCbGaD
Doxylamine—Orphenadrine—SCN1A—epilepsy syndrome	7.97e-05	0.0159	CrCbGaD
Doxylamine—Brompheniramine—CHRM1—epilepsy syndrome	7.88e-05	0.0158	CrCbGaD
Doxylamine—Dextropropoxyphene—OPRM1—epilepsy syndrome	7.21e-05	0.0144	CrCbGaD
Doxylamine—Immune system disorder—Gabapentin—epilepsy syndrome	6.96e-05	0.000388	CcSEcCtD
Doxylamine—Mediastinal disorder—Gabapentin—epilepsy syndrome	6.95e-05	0.000387	CcSEcCtD
Doxylamine—Hypersensitivity—Zonisamide—epilepsy syndrome	6.94e-05	0.000386	CcSEcCtD
Doxylamine—Vomiting—Midazolam—epilepsy syndrome	6.91e-05	0.000385	CcSEcCtD
Doxylamine—Diarrhoea—Vigabatrin—epilepsy syndrome	6.91e-05	0.000385	CcSEcCtD
Doxylamine—Asthenia—Felbamate—epilepsy syndrome	6.9e-05	0.000384	CcSEcCtD
Doxylamine—Anxiety—Valproic Acid—epilepsy syndrome	6.87e-05	0.000383	CcSEcCtD
Doxylamine—Tremor—Pregabalin—epilepsy syndrome	6.86e-05	0.000382	CcSEcCtD
Doxylamine—Feeling abnormal—Lamotrigine—epilepsy syndrome	6.85e-05	0.000382	CcSEcCtD
Doxylamine—Rash—Midazolam—epilepsy syndrome	6.85e-05	0.000382	CcSEcCtD
Doxylamine—Dizziness—Fosphenytoin—epilepsy syndrome	6.85e-05	0.000381	CcSEcCtD
Doxylamine—Dermatitis—Midazolam—epilepsy syndrome	6.84e-05	0.000381	CcSEcCtD
Doxylamine—Urticaria—Carbamazepine—epilepsy syndrome	6.83e-05	0.000381	CcSEcCtD
Doxylamine—Vomiting—Levetiracetam—epilepsy syndrome	6.82e-05	0.00038	CcSEcCtD
Doxylamine—Discomfort—Valproic Acid—epilepsy syndrome	6.81e-05	0.000379	CcSEcCtD
Doxylamine—Pruritus—Felbamate—epilepsy syndrome	6.8e-05	0.000379	CcSEcCtD
Doxylamine—Diarrhoea—Diazepam—epilepsy syndrome	6.8e-05	0.000379	CcSEcCtD
Doxylamine—Ill-defined disorder—Pregabalin—epilepsy syndrome	6.79e-05	0.000378	CcSEcCtD
Doxylamine—Rash—Levetiracetam—epilepsy syndrome	6.76e-05	0.000377	CcSEcCtD
Doxylamine—Dermatitis—Levetiracetam—epilepsy syndrome	6.76e-05	0.000377	CcSEcCtD
Doxylamine—Asthenia—Zonisamide—epilepsy syndrome	6.75e-05	0.000376	CcSEcCtD
Doxylamine—Agranulocytosis—Topiramate—epilepsy syndrome	6.74e-05	0.000376	CcSEcCtD
Doxylamine—Dry mouth—Valproic Acid—epilepsy syndrome	6.74e-05	0.000376	CcSEcCtD
Doxylamine—Agitation—Pregabalin—epilepsy syndrome	6.73e-05	0.000375	CcSEcCtD
Doxylamine—Erythema—Gabapentin—epilepsy syndrome	6.71e-05	0.000374	CcSEcCtD
Doxylamine—Angioedema—Pregabalin—epilepsy syndrome	6.69e-05	0.000373	CcSEcCtD
Doxylamine—Hypersensitivity—Clonazepam—epilepsy syndrome	6.68e-05	0.000372	CcSEcCtD
Doxylamine—Dizziness—Vigabatrin—epilepsy syndrome	6.67e-05	0.000372	CcSEcCtD
Doxylamine—Confusional state—Valproic Acid—epilepsy syndrome	6.66e-05	0.000371	CcSEcCtD
Doxylamine—Pruritus—Zonisamide—epilepsy syndrome	6.66e-05	0.000371	CcSEcCtD
Doxylamine—Hypersensitivity—Phenytoin—epilepsy syndrome	6.64e-05	0.00037	CcSEcCtD
Doxylamine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	6.61e-05	0.000368	CcSEcCtD
Doxylamine—Urticaria—Lamotrigine—epilepsy syndrome	6.6e-05	0.000368	CcSEcCtD
Doxylamine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.6e-05	0.000368	CcSEcCtD
Doxylamine—Bradycardia—Topiramate—epilepsy syndrome	6.6e-05	0.000368	CcSEcCtD
Doxylamine—Malaise—Pregabalin—epilepsy syndrome	6.6e-05	0.000368	CcSEcCtD
Doxylamine—Nausea—Propofol—epilepsy syndrome	6.6e-05	0.000367	CcSEcCtD
Doxylamine—Vomiting—Fosphenytoin—epilepsy syndrome	6.58e-05	0.000367	CcSEcCtD
Doxylamine—Diarrhoea—Felbamate—epilepsy syndrome	6.58e-05	0.000367	CcSEcCtD
Doxylamine—Vertigo—Pregabalin—epilepsy syndrome	6.57e-05	0.000366	CcSEcCtD
Doxylamine—Dizziness—Diazepam—epilepsy syndrome	6.57e-05	0.000366	CcSEcCtD
Doxylamine—Leukopenia—Pregabalin—epilepsy syndrome	6.55e-05	0.000365	CcSEcCtD
Doxylamine—Rash—Fosphenytoin—epilepsy syndrome	6.53e-05	0.000364	CcSEcCtD
Doxylamine—Dermatitis—Fosphenytoin—epilepsy syndrome	6.52e-05	0.000363	CcSEcCtD
Doxylamine—Asthenia—Clonazepam—epilepsy syndrome	6.51e-05	0.000363	CcSEcCtD
Doxylamine—Hepatitis—Topiramate—epilepsy syndrome	6.49e-05	0.000361	CcSEcCtD
Doxylamine—Nervous system disorder—Valproic Acid—epilepsy syndrome	6.48e-05	0.000361	CcSEcCtD
Doxylamine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	6.47e-05	0.00036	CcSEcCtD
Doxylamine—Palpitations—Pregabalin—epilepsy syndrome	6.47e-05	0.00036	CcSEcCtD
Doxylamine—Asthenia—Phenytoin—epilepsy syndrome	6.47e-05	0.00036	CcSEcCtD
Doxylamine—Nausea—Midazolam—epilepsy syndrome	6.45e-05	0.00036	CcSEcCtD
Doxylamine—Hallucination—Topiramate—epilepsy syndrome	6.45e-05	0.00036	CcSEcCtD
Doxylamine—Muscle spasms—Gabapentin—epilepsy syndrome	6.45e-05	0.000359	CcSEcCtD
Doxylamine—Tachycardia—Valproic Acid—epilepsy syndrome	6.45e-05	0.000359	CcSEcCtD
Doxylamine—Diarrhoea—Zonisamide—epilepsy syndrome	6.44e-05	0.000359	CcSEcCtD
Doxylamine—Brompheniramine—CHRM2—epilepsy syndrome	6.44e-05	0.0129	CrCbGaD
Doxylamine—Asthenia—Oxcarbazepine—epilepsy syndrome	6.43e-05	0.000358	CcSEcCtD
Doxylamine—Pruritus—Clonazepam—epilepsy syndrome	6.42e-05	0.000358	CcSEcCtD
Doxylamine—Vomiting—Vigabatrin—epilepsy syndrome	6.42e-05	0.000358	CcSEcCtD
Doxylamine—Urinary tract disorder—Topiramate—epilepsy syndrome	6.4e-05	0.000357	CcSEcCtD
Doxylamine—Methadone—OPRD1—epilepsy syndrome	6.39e-05	0.0128	CrCbGaD
Doxylamine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.39e-05	0.000356	CcSEcCtD
Doxylamine—Pruritus—Phenytoin—epilepsy syndrome	6.38e-05	0.000355	CcSEcCtD
Doxylamine—Nausea—Levetiracetam—epilepsy syndrome	6.37e-05	0.000355	CcSEcCtD
Doxylamine—Rash—Vigabatrin—epilepsy syndrome	6.36e-05	0.000355	CcSEcCtD
Doxylamine—Dizziness—Felbamate—epilepsy syndrome	6.36e-05	0.000354	CcSEcCtD
Doxylamine—Dermatitis—Vigabatrin—epilepsy syndrome	6.36e-05	0.000354	CcSEcCtD
Doxylamine—Urethral disorder—Topiramate—epilepsy syndrome	6.36e-05	0.000354	CcSEcCtD
Doxylamine—Pruritus—Oxcarbazepine—epilepsy syndrome	6.34e-05	0.000353	CcSEcCtD
Doxylamine—Convulsion—Pregabalin—epilepsy syndrome	6.34e-05	0.000353	CcSEcCtD
Doxylamine—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.34e-05	0.000353	CcSEcCtD
Doxylamine—Vomiting—Diazepam—epilepsy syndrome	6.32e-05	0.000352	CcSEcCtD
Doxylamine—Anorexia—Valproic Acid—epilepsy syndrome	6.3e-05	0.000351	CcSEcCtD
Doxylamine—Tremor—Gabapentin—epilepsy syndrome	6.29e-05	0.00035	CcSEcCtD
Doxylamine—Rash—Diazepam—epilepsy syndrome	6.27e-05	0.000349	CcSEcCtD
Doxylamine—Dermatitis—Diazepam—epilepsy syndrome	6.26e-05	0.000349	CcSEcCtD
Doxylamine—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.23e-05	0.000347	CcSEcCtD
Doxylamine—Dizziness—Zonisamide—epilepsy syndrome	6.23e-05	0.000347	CcSEcCtD
Doxylamine—Anxiety—Pregabalin—epilepsy syndrome	6.21e-05	0.000346	CcSEcCtD
Doxylamine—Diarrhoea—Clonazepam—epilepsy syndrome	6.21e-05	0.000346	CcSEcCtD
Doxylamine—Hypotension—Valproic Acid—epilepsy syndrome	6.17e-05	0.000344	CcSEcCtD
Doxylamine—Asthenia—Carbamazepine—epilepsy syndrome	6.17e-05	0.000344	CcSEcCtD
Doxylamine—Agitation—Gabapentin—epilepsy syndrome	6.17e-05	0.000344	CcSEcCtD
Doxylamine—Diarrhoea—Phenytoin—epilepsy syndrome	6.17e-05	0.000344	CcSEcCtD
Doxylamine—Discomfort—Pregabalin—epilepsy syndrome	6.16e-05	0.000343	CcSEcCtD
Doxylamine—Nausea—Fosphenytoin—epilepsy syndrome	6.15e-05	0.000343	CcSEcCtD
Doxylamine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.13e-05	0.000342	CcSEcCtD
Doxylamine—Erythema multiforme—Topiramate—epilepsy syndrome	6.13e-05	0.000342	CcSEcCtD
Doxylamine—Angioedema—Gabapentin—epilepsy syndrome	6.13e-05	0.000342	CcSEcCtD
Doxylamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.13e-05	0.000341	CcSEcCtD
Doxylamine—Vomiting—Felbamate—epilepsy syndrome	6.11e-05	0.000341	CcSEcCtD
Doxylamine—Dry mouth—Pregabalin—epilepsy syndrome	6.09e-05	0.000339	CcSEcCtD
Doxylamine—Pruritus—Carbamazepine—epilepsy syndrome	6.09e-05	0.000339	CcSEcCtD
Doxylamine—Rash—Felbamate—epilepsy syndrome	6.06e-05	0.000338	CcSEcCtD
Doxylamine—Eye disorder—Topiramate—epilepsy syndrome	6.06e-05	0.000338	CcSEcCtD
Doxylamine—Dermatitis—Felbamate—epilepsy syndrome	6.06e-05	0.000338	CcSEcCtD
Doxylamine—Malaise—Gabapentin—epilepsy syndrome	6.05e-05	0.000337	CcSEcCtD
Doxylamine—Clemastine—CYP2D6—epilepsy syndrome	6.03e-05	0.0121	CrCbGaD
Doxylamine—Vertigo—Gabapentin—epilepsy syndrome	6.03e-05	0.000336	CcSEcCtD
Doxylamine—Confusional state—Pregabalin—epilepsy syndrome	6.02e-05	0.000336	CcSEcCtD
Doxylamine—Flushing—Topiramate—epilepsy syndrome	6.02e-05	0.000335	CcSEcCtD
Doxylamine—Cardiac disorder—Topiramate—epilepsy syndrome	6.02e-05	0.000335	CcSEcCtD
Doxylamine—Leukopenia—Gabapentin—epilepsy syndrome	6.01e-05	0.000335	CcSEcCtD
Doxylamine—Dizziness—Clonazepam—epilepsy syndrome	6e-05	0.000334	CcSEcCtD
Doxylamine—Nausea—Vigabatrin—epilepsy syndrome	6e-05	0.000334	CcSEcCtD
Doxylamine—Vomiting—Zonisamide—epilepsy syndrome	5.99e-05	0.000333	CcSEcCtD
Doxylamine—Insomnia—Valproic Acid—epilepsy syndrome	5.98e-05	0.000333	CcSEcCtD
Doxylamine—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.97e-05	0.000333	CcSEcCtD
Doxylamine—Asthenia—Lamotrigine—epilepsy syndrome	5.97e-05	0.000332	CcSEcCtD
Doxylamine—Dizziness—Phenytoin—epilepsy syndrome	5.96e-05	0.000332	CcSEcCtD
Doxylamine—Rash—Zonisamide—epilepsy syndrome	5.94e-05	0.000331	CcSEcCtD
Doxylamine—Palpitations—Gabapentin—epilepsy syndrome	5.93e-05	0.00033	CcSEcCtD
Doxylamine—Dermatitis—Zonisamide—epilepsy syndrome	5.93e-05	0.00033	CcSEcCtD
Doxylamine—Dizziness—Oxcarbazepine—epilepsy syndrome	5.93e-05	0.00033	CcSEcCtD
Doxylamine—Nausea—Diazepam—epilepsy syndrome	5.9e-05	0.000329	CcSEcCtD
Doxylamine—Dyspnoea—Valproic Acid—epilepsy syndrome	5.89e-05	0.000328	CcSEcCtD
Doxylamine—Diarrhoea—Carbamazepine—epilepsy syndrome	5.89e-05	0.000328	CcSEcCtD
Doxylamine—Pruritus—Lamotrigine—epilepsy syndrome	5.88e-05	0.000328	CcSEcCtD
Doxylamine—Somnolence—Valproic Acid—epilepsy syndrome	5.87e-05	0.000327	CcSEcCtD
Doxylamine—Immune system disorder—Topiramate—epilepsy syndrome	5.86e-05	0.000326	CcSEcCtD
Doxylamine—Nervous system disorder—Pregabalin—epilepsy syndrome	5.86e-05	0.000326	CcSEcCtD
Doxylamine—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.85e-05	0.000326	CcSEcCtD
Doxylamine—Mediastinal disorder—Topiramate—epilepsy syndrome	5.84e-05	0.000326	CcSEcCtD
Doxylamine—Tachycardia—Pregabalin—epilepsy syndrome	5.83e-05	0.000325	CcSEcCtD
Doxylamine—Convulsion—Gabapentin—epilepsy syndrome	5.81e-05	0.000324	CcSEcCtD
Doxylamine—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.77e-05	0.000322	CcSEcCtD
Doxylamine—Vomiting—Clonazepam—epilepsy syndrome	5.77e-05	0.000321	CcSEcCtD
Doxylamine—Decreased appetite—Valproic Acid—epilepsy syndrome	5.74e-05	0.00032	CcSEcCtD
Doxylamine—Vomiting—Phenytoin—epilepsy syndrome	5.73e-05	0.000319	CcSEcCtD
Doxylamine—Rash—Clonazepam—epilepsy syndrome	5.72e-05	0.000319	CcSEcCtD
Doxylamine—Dermatitis—Clonazepam—epilepsy syndrome	5.72e-05	0.000318	CcSEcCtD
Doxylamine—Nausea—Felbamate—epilepsy syndrome	5.71e-05	0.000318	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.7e-05	0.000318	CcSEcCtD
Doxylamine—Vomiting—Oxcarbazepine—epilepsy syndrome	5.7e-05	0.000318	CcSEcCtD
Doxylamine—Fatigue—Valproic Acid—epilepsy syndrome	5.7e-05	0.000317	CcSEcCtD
Doxylamine—Anxiety—Gabapentin—epilepsy syndrome	5.69e-05	0.000317	CcSEcCtD
Doxylamine—Anorexia—Pregabalin—epilepsy syndrome	5.69e-05	0.000317	CcSEcCtD
Doxylamine—Dizziness—Carbamazepine—epilepsy syndrome	5.69e-05	0.000317	CcSEcCtD
Doxylamine—Diarrhoea—Lamotrigine—epilepsy syndrome	5.69e-05	0.000317	CcSEcCtD
Doxylamine—Rash—Phenytoin—epilepsy syndrome	5.68e-05	0.000317	CcSEcCtD
Doxylamine—Dermatitis—Phenytoin—epilepsy syndrome	5.68e-05	0.000316	CcSEcCtD
Doxylamine—Rash—Oxcarbazepine—epilepsy syndrome	5.65e-05	0.000315	CcSEcCtD
Doxylamine—Constipation—Valproic Acid—epilepsy syndrome	5.65e-05	0.000315	CcSEcCtD
Doxylamine—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.65e-05	0.000315	CcSEcCtD
Doxylamine—Erythema—Topiramate—epilepsy syndrome	5.65e-05	0.000315	CcSEcCtD
Doxylamine—Discomfort—Gabapentin—epilepsy syndrome	5.64e-05	0.000314	CcSEcCtD
Doxylamine—Nausea—Zonisamide—epilepsy syndrome	5.59e-05	0.000312	CcSEcCtD
Doxylamine—Dry mouth—Gabapentin—epilepsy syndrome	5.59e-05	0.000311	CcSEcCtD
Doxylamine—Hypotension—Pregabalin—epilepsy syndrome	5.58e-05	0.000311	CcSEcCtD
Doxylamine—Confusional state—Gabapentin—epilepsy syndrome	5.52e-05	0.000308	CcSEcCtD
Doxylamine—Dizziness—Lamotrigine—epilepsy syndrome	5.5e-05	0.000306	CcSEcCtD
Doxylamine—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.48e-05	0.000305	CcSEcCtD
Doxylamine—Vomiting—Carbamazepine—epilepsy syndrome	5.47e-05	0.000305	CcSEcCtD
Doxylamine—Doxepin—CHRM3—epilepsy syndrome	5.46e-05	0.0109	CrCbGaD
Doxylamine—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.44e-05	0.000303	CcSEcCtD
Doxylamine—Muscle spasms—Topiramate—epilepsy syndrome	5.43e-05	0.000302	CcSEcCtD
Doxylamine—Rash—Carbamazepine—epilepsy syndrome	5.42e-05	0.000302	CcSEcCtD
Doxylamine—Dermatitis—Carbamazepine—epilepsy syndrome	5.42e-05	0.000302	CcSEcCtD
Doxylamine—Insomnia—Pregabalin—epilepsy syndrome	5.4e-05	0.000301	CcSEcCtD
Doxylamine—Nausea—Clonazepam—epilepsy syndrome	5.39e-05	0.0003	CcSEcCtD
Doxylamine—Mepyramine—CYP2D6—epilepsy syndrome	5.38e-05	0.0107	CrCbGaD
Doxylamine—Nervous system disorder—Gabapentin—epilepsy syndrome	5.37e-05	0.000299	CcSEcCtD
Doxylamine—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.36e-05	0.000299	CcSEcCtD
Doxylamine—Nausea—Phenytoin—epilepsy syndrome	5.35e-05	0.000298	CcSEcCtD
Doxylamine—Tachycardia—Gabapentin—epilepsy syndrome	5.35e-05	0.000298	CcSEcCtD
Doxylamine—Dyspnoea—Pregabalin—epilepsy syndrome	5.32e-05	0.000297	CcSEcCtD
Doxylamine—Nausea—Oxcarbazepine—epilepsy syndrome	5.32e-05	0.000297	CcSEcCtD
Doxylamine—Somnolence—Pregabalin—epilepsy syndrome	5.31e-05	0.000296	CcSEcCtD
Doxylamine—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.29e-05	0.000295	CcSEcCtD
Doxylamine—Tremor—Topiramate—epilepsy syndrome	5.29e-05	0.000295	CcSEcCtD
Doxylamine—Vomiting—Lamotrigine—epilepsy syndrome	5.29e-05	0.000295	CcSEcCtD
Doxylamine—Urticaria—Valproic Acid—epilepsy syndrome	5.25e-05	0.000292	CcSEcCtD
Doxylamine—Rash—Lamotrigine—epilepsy syndrome	5.24e-05	0.000292	CcSEcCtD
Doxylamine—Ill-defined disorder—Topiramate—epilepsy syndrome	5.24e-05	0.000292	CcSEcCtD
Doxylamine—Dermatitis—Lamotrigine—epilepsy syndrome	5.24e-05	0.000292	CcSEcCtD
Doxylamine—Anorexia—Gabapentin—epilepsy syndrome	5.22e-05	0.000291	CcSEcCtD
Doxylamine—Decreased appetite—Pregabalin—epilepsy syndrome	5.19e-05	0.000289	CcSEcCtD
Doxylamine—Agitation—Topiramate—epilepsy syndrome	5.19e-05	0.000289	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.16e-05	0.000287	CcSEcCtD
Doxylamine—Fatigue—Pregabalin—epilepsy syndrome	5.15e-05	0.000287	CcSEcCtD
Doxylamine—Hypotension—Gabapentin—epilepsy syndrome	5.12e-05	0.000285	CcSEcCtD
Doxylamine—Nausea—Carbamazepine—epilepsy syndrome	5.11e-05	0.000285	CcSEcCtD
Doxylamine—Constipation—Pregabalin—epilepsy syndrome	5.11e-05	0.000285	CcSEcCtD
Doxylamine—Doxepin—CHRM1—epilepsy syndrome	5.1e-05	0.0102	CrCbGaD
Doxylamine—Malaise—Topiramate—epilepsy syndrome	5.09e-05	0.000284	CcSEcCtD
Doxylamine—Vertigo—Topiramate—epilepsy syndrome	5.07e-05	0.000283	CcSEcCtD
Doxylamine—Leukopenia—Topiramate—epilepsy syndrome	5.05e-05	0.000282	CcSEcCtD
Doxylamine—Palpitations—Topiramate—epilepsy syndrome	4.99e-05	0.000278	CcSEcCtD
Doxylamine—Tripelennamine—CYP2D6—epilepsy syndrome	4.97e-05	0.00994	CrCbGaD
Doxylamine—Amitriptyline—OPRD1—epilepsy syndrome	4.97e-05	0.00993	CrCbGaD
Doxylamine—Insomnia—Gabapentin—epilepsy syndrome	4.95e-05	0.000276	CcSEcCtD
Doxylamine—Nausea—Lamotrigine—epilepsy syndrome	4.94e-05	0.000275	CcSEcCtD
Doxylamine—Feeling abnormal—Pregabalin—epilepsy syndrome	4.92e-05	0.000274	CcSEcCtD
Doxylamine—Convulsion—Topiramate—epilepsy syndrome	4.89e-05	0.000273	CcSEcCtD
Doxylamine—Methadone—OPRM1—epilepsy syndrome	4.89e-05	0.00978	CrCbGaD
Doxylamine—Dyspnoea—Gabapentin—epilepsy syndrome	4.88e-05	0.000272	CcSEcCtD
Doxylamine—Somnolence—Gabapentin—epilepsy syndrome	4.87e-05	0.000271	CcSEcCtD
Doxylamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.87e-05	0.000271	CcSEcCtD
Doxylamine—Promazine—CHRM3—epilepsy syndrome	4.86e-05	0.00971	CrCbGaD
Doxylamine—Anxiety—Topiramate—epilepsy syndrome	4.79e-05	0.000267	CcSEcCtD
Doxylamine—Decreased appetite—Gabapentin—epilepsy syndrome	4.76e-05	0.000265	CcSEcCtD
Doxylamine—Discomfort—Topiramate—epilepsy syndrome	4.75e-05	0.000265	CcSEcCtD
Doxylamine—Urticaria—Pregabalin—epilepsy syndrome	4.74e-05	0.000264	CcSEcCtD
Doxylamine—Asthenia—Valproic Acid—epilepsy syndrome	4.74e-05	0.000264	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.73e-05	0.000263	CcSEcCtD
Doxylamine—Fatigue—Gabapentin—epilepsy syndrome	4.72e-05	0.000263	CcSEcCtD
Doxylamine—Dry mouth—Topiramate—epilepsy syndrome	4.7e-05	0.000262	CcSEcCtD
Doxylamine—Constipation—Gabapentin—epilepsy syndrome	4.68e-05	0.000261	CcSEcCtD
Doxylamine—Pruritus—Valproic Acid—epilepsy syndrome	4.67e-05	0.00026	CcSEcCtD
Doxylamine—Confusional state—Topiramate—epilepsy syndrome	4.65e-05	0.000259	CcSEcCtD
Doxylamine—Carbinoxamine—CYP2C19—epilepsy syndrome	4.59e-05	0.00917	CrCbGaD
Doxylamine—Benzphetamine—ADRA2A—epilepsy syndrome	4.57e-05	0.00913	CrCbGaD
Doxylamine—Promazine—CHRM1—epilepsy syndrome	4.53e-05	0.00905	CrCbGaD
Doxylamine—Diarrhoea—Valproic Acid—epilepsy syndrome	4.52e-05	0.000252	CcSEcCtD
Doxylamine—Cyclobenzaprine—HTR2A—epilepsy syndrome	4.52e-05	0.00904	CrCbGaD
Doxylamine—Nervous system disorder—Topiramate—epilepsy syndrome	4.52e-05	0.000252	CcSEcCtD
Doxylamine—Feeling abnormal—Gabapentin—epilepsy syndrome	4.51e-05	0.000251	CcSEcCtD
Doxylamine—Thrombocytopenia—Topiramate—epilepsy syndrome	4.51e-05	0.000251	CcSEcCtD
Doxylamine—Tachycardia—Topiramate—epilepsy syndrome	4.5e-05	0.000251	CcSEcCtD
Doxylamine—Hyperhidrosis—Topiramate—epilepsy syndrome	4.45e-05	0.000248	CcSEcCtD
Doxylamine—Hypersensitivity—Pregabalin—epilepsy syndrome	4.4e-05	0.000245	CcSEcCtD
Doxylamine—Anorexia—Topiramate—epilepsy syndrome	4.39e-05	0.000245	CcSEcCtD
Doxylamine—Dizziness—Valproic Acid—epilepsy syndrome	4.37e-05	0.000243	CcSEcCtD
Doxylamine—Urticaria—Gabapentin—epilepsy syndrome	4.35e-05	0.000242	CcSEcCtD
Doxylamine—Hypotension—Topiramate—epilepsy syndrome	4.31e-05	0.00024	CcSEcCtD
Doxylamine—Diphenhydramine—CHRM2—epilepsy syndrome	4.29e-05	0.00857	CrCbGaD
Doxylamine—Asthenia—Pregabalin—epilepsy syndrome	4.29e-05	0.000239	CcSEcCtD
Doxylamine—Imipramine—CHRM3—epilepsy syndrome	4.25e-05	0.0085	CrCbGaD
Doxylamine—Pruritus—Pregabalin—epilepsy syndrome	4.23e-05	0.000235	CcSEcCtD
Doxylamine—Amitriptyline—CHRM3—epilepsy syndrome	4.23e-05	0.00845	CrCbGaD
Doxylamine—Vomiting—Valproic Acid—epilepsy syndrome	4.2e-05	0.000234	CcSEcCtD
Doxylamine—Insomnia—Topiramate—epilepsy syndrome	4.17e-05	0.000232	CcSEcCtD
Doxylamine—Rash—Valproic Acid—epilepsy syndrome	4.17e-05	0.000232	CcSEcCtD
Doxylamine—Dermatitis—Valproic Acid—epilepsy syndrome	4.16e-05	0.000232	CcSEcCtD
Doxylamine—Doxepin—CHRM2—epilepsy syndrome	4.16e-05	0.00832	CrCbGaD
Doxylamine—Cyclobenzaprine—CYP2D6—epilepsy syndrome	4.13e-05	0.00826	CrCbGaD
Doxylamine—Chlorphenamine—SLC6A4—epilepsy syndrome	4.11e-05	0.00822	CrCbGaD
Doxylamine—Dyspnoea—Topiramate—epilepsy syndrome	4.11e-05	0.000229	CcSEcCtD
Doxylamine—Somnolence—Topiramate—epilepsy syndrome	4.1e-05	0.000228	CcSEcCtD
Doxylamine—Diarrhoea—Pregabalin—epilepsy syndrome	4.09e-05	0.000228	CcSEcCtD
Doxylamine—Orphenadrine—CHRM2—epilepsy syndrome	4.05e-05	0.00811	CrCbGaD
Doxylamine—Hypersensitivity—Gabapentin—epilepsy syndrome	4.04e-05	0.000225	CcSEcCtD
Doxylamine—Decreased appetite—Topiramate—epilepsy syndrome	4.01e-05	0.000223	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.98e-05	0.000222	CcSEcCtD
Doxylamine—Fatigue—Topiramate—epilepsy syndrome	3.97e-05	0.000221	CcSEcCtD
Doxylamine—Brompheniramine—CYP2C19—epilepsy syndrome	3.97e-05	0.00794	CrCbGaD
Doxylamine—Imipramine—CHRM1—epilepsy syndrome	3.97e-05	0.00793	CrCbGaD
Doxylamine—Dizziness—Pregabalin—epilepsy syndrome	3.95e-05	0.00022	CcSEcCtD
Doxylamine—Amitriptyline—CHRM1—epilepsy syndrome	3.94e-05	0.00788	CrCbGaD
Doxylamine—Constipation—Topiramate—epilepsy syndrome	3.94e-05	0.00022	CcSEcCtD
Doxylamine—Asthenia—Gabapentin—epilepsy syndrome	3.93e-05	0.000219	CcSEcCtD
Doxylamine—Nausea—Valproic Acid—epilepsy syndrome	3.92e-05	0.000219	CcSEcCtD
Doxylamine—Pruritus—Gabapentin—epilepsy syndrome	3.87e-05	0.000216	CcSEcCtD
Doxylamine—Amitriptyline—OPRM1—epilepsy syndrome	3.8e-05	0.0076	CrCbGaD
Doxylamine—Vomiting—Pregabalin—epilepsy syndrome	3.8e-05	0.000212	CcSEcCtD
Doxylamine—Feeling abnormal—Topiramate—epilepsy syndrome	3.8e-05	0.000212	CcSEcCtD
Doxylamine—Rash—Pregabalin—epilepsy syndrome	3.77e-05	0.00021	CcSEcCtD
Doxylamine—Dermatitis—Pregabalin—epilepsy syndrome	3.76e-05	0.00021	CcSEcCtD
Doxylamine—Diarrhoea—Gabapentin—epilepsy syndrome	3.75e-05	0.000209	CcSEcCtD
Doxylamine—Tamoxifen—ABCC2—epilepsy syndrome	3.71e-05	0.00741	CrCbGaD
Doxylamine—Promazine—CHRM2—epilepsy syndrome	3.7e-05	0.00739	CrCbGaD
Doxylamine—Urticaria—Topiramate—epilepsy syndrome	3.66e-05	0.000204	CcSEcCtD
Doxylamine—Dizziness—Gabapentin—epilepsy syndrome	3.62e-05	0.000202	CcSEcCtD
Doxylamine—Doxepin—ADRA2A—epilepsy syndrome	3.55e-05	0.0071	CrCbGaD
Doxylamine—Nausea—Pregabalin—epilepsy syndrome	3.55e-05	0.000198	CcSEcCtD
Doxylamine—Vomiting—Gabapentin—epilepsy syndrome	3.48e-05	0.000194	CcSEcCtD
Doxylamine—Atomoxetine—SLC6A4—epilepsy syndrome	3.46e-05	0.00691	CrCbGaD
Doxylamine—Rash—Gabapentin—epilepsy syndrome	3.45e-05	0.000192	CcSEcCtD
Doxylamine—Dermatitis—Gabapentin—epilepsy syndrome	3.45e-05	0.000192	CcSEcCtD
Doxylamine—Toremifene—ABCB1—epilepsy syndrome	3.41e-05	0.00683	CrCbGaD
Doxylamine—Carbinoxamine—CYP2D6—epilepsy syndrome	3.4e-05	0.0068	CrCbGaD
Doxylamine—Hypersensitivity—Topiramate—epilepsy syndrome	3.39e-05	0.000189	CcSEcCtD
Doxylamine—Asthenia—Topiramate—epilepsy syndrome	3.31e-05	0.000184	CcSEcCtD
Doxylamine—Tamoxifen—ABCG2—epilepsy syndrome	3.28e-05	0.00655	CrCbGaD
Doxylamine—Atomoxetine—CYP2C19—epilepsy syndrome	3.28e-05	0.00655	CrCbGaD
Doxylamine—Pruritus—Topiramate—epilepsy syndrome	3.26e-05	0.000182	CcSEcCtD
Doxylamine—Nausea—Gabapentin—epilepsy syndrome	3.25e-05	0.000181	CcSEcCtD
Doxylamine—Imipramine—CHRM2—epilepsy syndrome	3.24e-05	0.00647	CrCbGaD
Doxylamine—Imipramine—HTR7—epilepsy syndrome	3.22e-05	0.00644	CrCbGaD
Doxylamine—Amitriptyline—CHRM2—epilepsy syndrome	3.22e-05	0.00643	CrCbGaD
Doxylamine—Amitriptyline—HTR7—epilepsy syndrome	3.2e-05	0.0064	CrCbGaD
Doxylamine—Promazine—ADRA2A—epilepsy syndrome	3.16e-05	0.00631	CrCbGaD
Doxylamine—Diarrhoea—Topiramate—epilepsy syndrome	3.15e-05	0.000176	CcSEcCtD
Doxylamine—Dizziness—Topiramate—epilepsy syndrome	3.05e-05	0.00017	CcSEcCtD
Doxylamine—Brompheniramine—CYP2D6—epilepsy syndrome	2.95e-05	0.00589	CrCbGaD
Doxylamine—Vomiting—Topiramate—epilepsy syndrome	2.93e-05	0.000163	CcSEcCtD
Doxylamine—Rash—Topiramate—epilepsy syndrome	2.91e-05	0.000162	CcSEcCtD
Doxylamine—Dermatitis—Topiramate—epilepsy syndrome	2.9e-05	0.000162	CcSEcCtD
Doxylamine—Chlorphenamine—CYP2D6—epilepsy syndrome	2.89e-05	0.00578	CrCbGaD
Doxylamine—Dextropropoxyphene—CYP2D6—epilepsy syndrome	2.79e-05	0.00558	CrCbGaD
Doxylamine—Amitriptyline—ADRA2A—epilepsy syndrome	2.75e-05	0.00549	CrCbGaD
Doxylamine—Nausea—Topiramate—epilepsy syndrome	2.74e-05	0.000152	CcSEcCtD
Doxylamine—Doxepin—SLC6A4—epilepsy syndrome	2.71e-05	0.00542	CrCbGaD
Doxylamine—Atomoxetine—HTR2A—epilepsy syndrome	2.66e-05	0.00531	CrCbGaD
Doxylamine—Diphenhydramine—CYP2C19—epilepsy syndrome	2.65e-05	0.00529	CrCbGaD
Doxylamine—Tamoxifen—CYP2C19—epilepsy syndrome	2.58e-05	0.00515	CrCbGaD
Doxylamine—Doxepin—CYP2C19—epilepsy syndrome	2.57e-05	0.00513	CrCbGaD
Doxylamine—Methadone—CYP2C19—epilepsy syndrome	2.55e-05	0.00511	CrCbGaD
Doxylamine—Atomoxetine—CYP2D6—epilepsy syndrome	2.43e-05	0.00486	CrCbGaD
Doxylamine—Promazine—CYP2C19—epilepsy syndrome	2.28e-05	0.00456	CrCbGaD
Doxylamine—Imipramine—SLC6A4—epilepsy syndrome	2.11e-05	0.00421	CrCbGaD
Doxylamine—Amitriptyline—SLC6A4—epilepsy syndrome	2.09e-05	0.00419	CrCbGaD
Doxylamine—Doxepin—HTR2A—epilepsy syndrome	2.08e-05	0.00416	CrCbGaD
Doxylamine—Imipramine—CYP2C19—epilepsy syndrome	2e-05	0.004	CrCbGaD
Doxylamine—Amitriptyline—CYP2C19—epilepsy syndrome	1.99e-05	0.00397	CrCbGaD
Doxylamine—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	1.97e-05	0.000479	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—OXT—epilepsy syndrome	1.97e-05	0.000477	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CRH—epilepsy syndrome	1.97e-05	0.000477	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCL3—epilepsy syndrome	1.97e-05	0.000477	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CXCL2—epilepsy syndrome	1.97e-05	0.000477	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	1.96e-05	0.000477	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	1.96e-05	0.000477	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.96e-05	0.000476	CbGpPWpGaD
Doxylamine—Diphenhydramine—CYP2D6—epilepsy syndrome	1.96e-05	0.00392	CrCbGaD
Doxylamine—CHRM1—GPCR downstream signaling—CCR2—epilepsy syndrome	1.96e-05	0.000475	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—SST—epilepsy syndrome	1.96e-05	0.000475	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.96e-05	0.000475	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.92e-05	0.000467	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	1.92e-05	0.000467	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	1.92e-05	0.000467	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	1.92e-05	0.000467	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	1.92e-05	0.000467	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.92e-05	0.000467	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCR9—epilepsy syndrome	1.92e-05	0.000465	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SSTR1—epilepsy syndrome	1.92e-05	0.000465	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NPY2R—epilepsy syndrome	1.92e-05	0.000465	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCR8—epilepsy syndrome	1.92e-05	0.000465	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.92e-05	0.000465	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.92e-05	0.000465	CbGpPWpGaD
Doxylamine—Tamoxifen—CYP2D6—epilepsy syndrome	1.91e-05	0.00382	CrCbGaD
Doxylamine—Doxepin—CYP2D6—epilepsy syndrome	1.9e-05	0.00381	CrCbGaD
Doxylamine—Methadone—CYP2D6—epilepsy syndrome	1.89e-05	0.00379	CrCbGaD
Doxylamine—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	1.88e-05	0.000458	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	1.88e-05	0.000458	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GRM4—epilepsy syndrome	1.88e-05	0.000456	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GRM3—epilepsy syndrome	1.88e-05	0.000456	CbGpPWpGaD
Doxylamine—Promazine—HTR2A—epilepsy syndrome	1.85e-05	0.0037	CrCbGaD
Doxylamine—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	1.85e-05	0.000449	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	1.85e-05	0.000449	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.85e-05	0.000448	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.85e-05	0.000448	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DUSP4—epilepsy syndrome	1.84e-05	0.000448	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SSTR2—epilepsy syndrome	1.84e-05	0.000448	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.84e-05	0.000447	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.84e-05	0.000447	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	1.81e-05	0.00044	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CNR1—epilepsy syndrome	1.81e-05	0.000439	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.81e-05	0.000438	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.8e-05	0.000437	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	1.79e-05	0.000434	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PGF—epilepsy syndrome	1.79e-05	0.000434	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—SST—epilepsy syndrome	1.78e-05	0.000433	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	1.78e-05	0.000433	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GRM8—epilepsy syndrome	1.78e-05	0.000433	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PGF—epilepsy syndrome	1.78e-05	0.000433	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCR2—epilepsy syndrome	1.78e-05	0.000432	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—SST—epilepsy syndrome	1.78e-05	0.000432	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	1.77e-05	0.000429	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR7—epilepsy syndrome	1.76e-05	0.000428	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	1.75e-05	0.000425	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.74e-05	0.000424	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—POMC—epilepsy syndrome	1.74e-05	0.000423	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.74e-05	0.000422	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	1.71e-05	0.000416	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CCL2—epilepsy syndrome	1.71e-05	0.000414	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	1.7e-05	0.000414	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	1.7e-05	0.000414	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GNAO1—epilepsy syndrome	1.7e-05	0.000413	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—OPRD1—epilepsy syndrome	1.7e-05	0.000413	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	1.68e-05	0.000409	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AKT3—epilepsy syndrome	1.68e-05	0.000408	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.68e-05	0.000407	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.68e-05	0.000407	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.67e-05	0.000406	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.67e-05	0.000406	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	1.65e-05	0.0004	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CNR1—epilepsy syndrome	1.64e-05	0.000398	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.64e-05	0.000398	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	1.63e-05	0.000397	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	1.63e-05	0.000397	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	1.63e-05	0.000397	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	1.63e-05	0.000397	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.63e-05	0.000397	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GRM1—epilepsy syndrome	1.63e-05	0.000396	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCR7—epilepsy syndrome	1.63e-05	0.000396	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PDYN—epilepsy syndrome	1.63e-05	0.000396	CbGpPWpGaD
Doxylamine—Imipramine—HTR2A—epilepsy syndrome	1.62e-05	0.00324	CrCbGaD
Doxylamine—Amitriptyline—HTR2A—epilepsy syndrome	1.61e-05	0.00322	CrCbGaD
Doxylamine—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	1.61e-05	0.00039	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR7—epilepsy syndrome	1.6e-05	0.000389	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.56e-05	0.000378	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.55e-05	0.000377	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.54e-05	0.000373	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GAL—epilepsy syndrome	1.54e-05	0.000373	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	1.54e-05	0.000373	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.53e-05	0.000372	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GAL—epilepsy syndrome	1.53e-05	0.000372	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GFAP—epilepsy syndrome	1.53e-05	0.000372	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	1.53e-05	0.000371	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AKT3—epilepsy syndrome	1.52e-05	0.00037	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	1.52e-05	0.000369	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	1.52e-05	0.000369	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	1.52e-05	0.000369	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CASP2—epilepsy syndrome	1.51e-05	0.000368	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GRM5—epilepsy syndrome	1.51e-05	0.000368	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CHRM3—epilepsy syndrome	1.51e-05	0.000368	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	1.49e-05	0.000361	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AVP—epilepsy syndrome	1.48e-05	0.00036	CbGpPWpGaD
Doxylamine—Imipramine—CYP2D6—epilepsy syndrome	1.48e-05	0.00296	CrCbGaD
Doxylamine—Amitriptyline—CYP2D6—epilepsy syndrome	1.47e-05	0.00294	CrCbGaD
Doxylamine—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.46e-05	0.000354	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.45e-05	0.000353	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	1.43e-05	0.000347	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.43e-05	0.000347	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.43e-05	0.000347	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.42e-05	0.000346	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.42e-05	0.000346	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.42e-05	0.000346	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	1.4e-05	0.000339	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.39e-05	0.000338	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	1.39e-05	0.000337	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.39e-05	0.000336	CbGpPWpGaD
Doxylamine—Tamoxifen—ABCB1—epilepsy syndrome	1.36e-05	0.00273	CrCbGaD
Doxylamine—Doxepin—ABCB1—epilepsy syndrome	1.36e-05	0.00272	CrCbGaD
Doxylamine—Methadone—ABCB1—epilepsy syndrome	1.35e-05	0.0027	CrCbGaD
Doxylamine—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	1.35e-05	0.000328	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.35e-05	0.000327	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	1.33e-05	0.000324	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.33e-05	0.000322	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	1.31e-05	0.000318	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	1.31e-05	0.000317	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.27e-05	0.000307	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.26e-05	0.000306	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	1.24e-05	0.000301	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.24e-05	0.000301	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.23e-05	0.0003	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.23e-05	0.0003	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.21e-05	0.000293	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	1.21e-05	0.000293	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	1.2e-05	0.000292	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.2e-05	0.000292	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	1.17e-05	0.000285	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.17e-05	0.000284	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	1.16e-05	0.000283	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	1.16e-05	0.000283	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	1.16e-05	0.000283	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	1.16e-05	0.000283	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	1.16e-05	0.000283	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.16e-05	0.000282	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	1.16e-05	0.000282	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.16e-05	0.000282	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	1.16e-05	0.000282	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.16e-05	0.000282	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	1.15e-05	0.000279	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.15e-05	0.000278	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.12e-05	0.000273	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.12e-05	0.000272	CbGpPWpGaD
Doxylamine—Amitriptyline—ALB—epilepsy syndrome	1.1e-05	0.0022	CrCbGaD
Doxylamine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.09e-05	0.000264	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	1.08e-05	0.000263	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	1.08e-05	0.000263	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.08e-05	0.000263	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.08e-05	0.000262	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.08e-05	0.000262	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	1.07e-05	0.000259	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.06e-05	0.000258	CbGpPWpGaD
Doxylamine—Imipramine—ABCB1—epilepsy syndrome	1.06e-05	0.00211	CrCbGaD
Doxylamine—HRH1—Signaling Pathways—SST—epilepsy syndrome	1.05e-05	0.000256	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	1.05e-05	0.000256	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	1.05e-05	0.000256	CbGpPWpGaD
Doxylamine—Amitriptyline—ABCB1—epilepsy syndrome	1.05e-05	0.0021	CrCbGaD
Doxylamine—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.05e-05	0.000255	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SST—epilepsy syndrome	1.05e-05	0.000255	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.05e-05	0.000255	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	1.04e-05	0.000254	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.04e-05	0.000253	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.03e-05	0.00025	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.03e-05	0.000249	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	1.03e-05	0.000249	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	1.02e-05	0.000248	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	9.9e-06	0.00024	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	9.9e-06	0.00024	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	9.89e-06	0.00024	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	9.87e-06	0.00024	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	9.87e-06	0.00024	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	9.86e-06	0.000239	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	9.86e-06	0.000239	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	9.82e-06	0.000239	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	9.82e-06	0.000238	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	9.79e-06	0.000238	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	9.72e-06	0.000236	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	9.72e-06	0.000236	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	9.69e-06	0.000235	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	9.69e-06	0.000235	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	9.68e-06	0.000235	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	9.65e-06	0.000234	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	9.48e-06	0.00023	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	9.45e-06	0.00023	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	9.21e-06	0.000224	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	9.18e-06	0.000223	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	9.04e-06	0.000219	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	9.01e-06	0.000219	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	8.98e-06	0.000218	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	8.95e-06	0.000217	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	8.83e-06	0.000214	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	8.8e-06	0.000214	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	8.79e-06	0.000213	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	8.76e-06	0.000213	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	8.35e-06	0.000203	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	8.32e-06	0.000202	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	8.26e-06	0.000201	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	8.24e-06	0.0002	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	8.24e-06	0.0002	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	8.22e-06	0.0002	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	7.98e-06	0.000194	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	7.96e-06	0.000193	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	7.55e-06	0.000183	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	7.52e-06	0.000183	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	7.34e-06	0.000178	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	7.32e-06	0.000178	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	7.31e-06	0.000178	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	7.3e-06	0.000177	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	7.29e-06	0.000177	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	7.28e-06	0.000177	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.06e-06	0.000171	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.03e-06	0.000171	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	6.98e-06	0.000169	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	6.95e-06	0.000169	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	6.79e-06	0.000165	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	6.76e-06	0.000164	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	6.64e-06	0.000161	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	6.62e-06	0.000161	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	6.31e-06	0.000153	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	6.3e-06	0.000153	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	6.29e-06	0.000153	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	6.28e-06	0.000153	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	6.17e-06	0.00015	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	6.15e-06	0.000149	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	6.05e-06	0.000147	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	6.03e-06	0.000146	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	5.82e-06	0.000141	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	5.8e-06	0.000141	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	5.8e-06	0.000141	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	5.78e-06	0.00014	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	5.3e-06	0.000129	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	5.29e-06	0.000128	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	5.19e-06	0.000126	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	5.17e-06	0.000126	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	4.69e-06	0.000114	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	4.68e-06	0.000114	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	4.35e-06	0.000106	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	4.34e-06	0.000105	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	4.27e-06	0.000104	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	4.26e-06	0.000103	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.96e-06	9.62e-05	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.95e-06	9.59e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	3.93e-06	9.54e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	3.91e-06	9.51e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	3.81e-06	9.26e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	3.8e-06	9.23e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	3.71e-06	9.01e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	3.7e-06	8.98e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	3.6e-06	8.74e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.59e-06	8.71e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	3.42e-06	8.31e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	3.41e-06	8.28e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	3.33e-06	8.09e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.32e-06	8.07e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	2.13e-06	5.16e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.12e-06	5.15e-05	CbGpPWpGaD
